about
Impact of immigration on the cost of emergency visits in Barcelona (Spain).Incremental cost of nosocomial bacteremia according to the focus of infection and antibiotic sensitivity of the causative microorganism in a university hospital.Eosinophil count and neutrophil-lymphocyte count ratio as prognostic markers in patients with bacteremia: a retrospective cohort studyPatient risk factors for developing a drug-related problem in a cardiology ward.Cost Attributable to Nosocomial Bacteremia. Analysis According to Microorganism and Antimicrobial Sensitivity in a University Hospital in Barcelona.Importance of appropriateness of empiric antibiotic therapy on clinical outcomes in intra-abdominal infections.Computerized pharmacy surveillance and alert system for drug-related problems.[Economic impact of nosocomial bacteraemia. A comparison of three calculation methods].Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections.Design of a score to identify hospitalized patients at risk of drug-related problems.Validation of a score to identify inpatients at risk of a drug-related problem during a 4-year period.Impacto de una intervención de autoevaluación clínica sobre la adecuación de la estancia hospitalariaCostes asociados a las bacteriemias nosocomiales en un hospital universitarioResultados de un proyecto multidisciplinar y multifocal para la disminución de la bacteriemia causada por catéter venoso central, en pacientes no críticos, en un hospital universitarioRisk factors for multidrug-resistant Pseudomonas aeruginosa acquisition. Impact of antibiotic use in a double case–control studyBacteriemia comunitaria tratada o identificada de forma ambulatoria tras el alta de un servicio de urgenciasRisk adjustment: beyond patient classification systems[Evaluation of the impact of the introduction of a functional knee arthroplasty unit]
P50
Q33269866-C58B92D1-111F-4F01-9BE9-6B765A79E68BQ33627069-E24D3279-2BE9-4FB2-B408-1C87F3717A22Q34389008-9D6998F1-5013-47C4-AD16-E8B53ADF6AF6Q34764219-A45F678F-75C1-4A5C-AD40-ADB547B40F6EQ35982731-9FF97BE3-A790-4429-BC2F-A3AC6E05F67AQ36434991-FE860DA6-662F-4DA6-97E7-6FED408C9BF6Q39025617-0B24188E-E37B-415C-81AE-418F3A8D715AQ40911431-24DCE385-60DF-487E-A36F-9E48A81CE7C6Q45981762-0A251C37-A7F5-4B34-ACA1-2882CDD99697Q46155882-A93AE882-D1A3-4183-8273-11ADAFB97AADQ55510191-8688630D-AD39-4CFB-A1C2-6409935D8C2AQ57753889-95C7FAA7-38A1-43F0-AB3A-632624295CFAQ61766668-A106FDC7-0A87-4A95-BA88-FC2AB1F71D43Q61766687-3765B4EA-A163-4570-96DE-C124154C23A2Q61766691-8447B8C5-F335-40DE-9727-5866A0F5D777Q61766699-227602B2-7D72-4180-9A5B-95787DD59560Q77323766-768F73BB-7065-4B7B-8944-8CBB9B93C154Q84094399-C398F9D5-5409-41FA-B449-5B3BADAB88EA
P50
description
researcher ORCID ID = 0000-0003-4702-3472
@en
wetenschapper
@nl
name
Marta Riu
@ast
Marta Riu
@en
Marta Riu
@es
Marta Riu
@nl
type
label
Marta Riu
@ast
Marta Riu
@en
Marta Riu
@es
Marta Riu
@nl
prefLabel
Marta Riu
@ast
Marta Riu
@en
Marta Riu
@es
Marta Riu
@nl
P106
P1153
56342382600
P21
P31
P496
0000-0003-4702-3472